(Alliance News) - Collagen Solutions PLC, a developer and manufacturer of biomaterials for the enhancement and extension of human life, on Wednesday said loss for the year to March-end will be materially greater than anticipated due to increased costs from a development and manufacturing contract which has taken longer than originally anticipated.
The company expects to record a one-time write down of GBP900,000 relating to the delayed contract. It also expects delays in certain contracts to impact annual revenue.
In financial 2019, the company recorded a pretax loss of GBP1.8 million and revenue of GBP4.5 million.
On Covid-19 outbreak, the company said it has put in place health and safety measures aligned with the government and industry recommendations. This includes a suspension of all non-essential travel, flexibility for employees faced with indirect effects of these measures, and of course a requirement to remain at home for any sick employees.
Shares in Collagen Solutions closed 44% lower at 1.10 pence each in London on Wednesday.
By Tapan Panchal; tapanpanchal@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.
